LGC launches SARS-CoV-2 Delta Variant quality solution
News - Safe, non-infectious, and replication deficient quality solution for Delta variant detection and analysis
17 September 2021
Measurement science improves standardisation of SARS-CoV-2 quantification
News - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic
12 October 2021
LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York
News - Nexar workflow continues to enable simple, scalable, and cost-effective testing
29 October 2021
LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA
News - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing
27 April 2022